6min chapter

The Readout Loud cover image

341: NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers

The Readout Loud

CHAPTER

The Biotech Innovation Dilemma

This chapter explores the evolving landscape of drug development through the lens of biotech companies Absci and Generate, focusing on their antibody candidates for COVID and asthma. It examines the skepticism surrounding the innovation and efficacy of AI-assisted drug design, as well as the broader implications of transparency in the biotech industry.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode